T2 Biosystems Cash Conversion Cycle 2011-2026 | TTOO

Annual Cash Conversion Cycle T2 Biosystems

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
91.3	95.3	66.6	130	120	108	57.7	20.8	-66.4	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
130	-66.4	69.2

Quarterly Cash Conversion Cycle T2 Biosystems

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
75.8	67.8	66.4	-	74.4	60.4	76	-	53.3	54.7	59.9	-	50.4	54.6	59.9	-	88.7	182	142	84	154	143	118	90.9	66.1	41.5	44.5	25.7	38.5	44.6	38.5	32.8	27.5	30.1	29	33.3	32.1	59.7	138	154	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
182	25.7	72

Cash Conversion Cycle of other stocks in the Diagnostics research industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	50.2	-	-6.23 %	$ 30.6 M	Germany
Aspira Women's Health AWH	1.01 K	-	-6.19 %	$ 10.5 M	USA
Agilent Technologies A	111	$ 116.92	2.68 %	$ 35.5 B	USA
Biocept BIOC	78.1	-	-13.05 %	$ 7.29 M	USA
DermTech DMTK	66.7	-	-11.32 %	$ 2.94 M	USA
Castle Biosciences CSTL	45.9	$ 25.62	3.18 %	$ 712 M	USA
Enzo Biochem ENZ	154	-	-8.98 %	$ 14.8 K	USA
Danaher Corporation DHR	77.5	$ 195.29	2.24 %	$ 139 B	USA
Exact Sciences Corporation EXAS	42.5	-	-	$ 19.8 B	USA
Fulgent Genetics FLGT	42.4	$ 16.25	2.14 %	$ 491 M	USA
CareDx, Inc CDNA	51.5	$ 18.15	2.72 %	$ 967 M	USA
Guardant Health GH	79.6	$ 94.73	1.53 %	$ 11.9 B	USA
DexCom DXCM	134	$ 65.41	3.64 %	$ 25.5 B	USA
Akumin AKU	36.1	-	-17.87 %	$ 25.9 M	Canada
Heska Corporation HSKA	138	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	104	-	-20.0 %	$ 1.06 M	USA
Burning Rock Biotech Limited BNR	149	$ 16.5	2.52 %	$ 178 M	China
Co-Diagnostics CODX	-2.46 K	$ 4.4	101.83 %	$ 5.85 M	USA
ICON Public Limited Company ICLR	62	$ 108.69	1.43 %	$ 8.97 B	Irlanda
Accelerate Diagnostics AXDX	364	-	-61.36 %	$ 2.46 M	USA
Illumina ILMN	142	$ 127.4	0.76 %	$ 20.3 B	USA
IQVIA Holdings IQV	73.9	$ 174.05	2.06 %	$ 29.9 B	USA
Global Cord Blood Corporation CO	184	-	-	$ 399 M	China
Genetic Technologies Limited GENE	11 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	142	-	0.12 %	$ 80.1 M	China
Laboratory Corporation of America Holdings LH	40.3	$ 274.58	2.01 %	$ 22.8 B	USA
Lantheus Holdings LNTH	97.3	$ 79.47	1.78 %	$ 5.36 B	USA
Charles River Laboratories International CRL	65	$ 176.29	3.94 %	$ 8.74 B	USA
PRA Health Sciences, Inc. PRAH	1.21 K	-	-	$ 10.7 B	USA
Motus GI Holdings MOTS	3.45 K	-	-34.28 %	$ 263 K	Israel
Medpace Holdings MEDP	50.4	$ 522.84	2.82 %	$ 15.1 B	USA
Mettler-Toledo International MTD	66.4	$ 1 318.82	3.84 %	$ 27.2 B	Schweiz
Myriad Genetics MYGN	49.3	$ 4.87	2.64 %	$ 451 M	USA
Biodesix BDSX	41.7	$ 14.75	1.48 %	$ 1.91 B	USA
NeoGenomics NEO	82.4	$ 8.36	3.72 %	$ 1.07 B	USA
Neogen Corporation NEOG	150	$ 10.53	5.51 %	$ 2.28 B	USA
OpGen OPGN	4.66	-	-16.95 %	$ 1.54 M	USA
Natera NTRA	81.5	$ 212.64	1.61 %	$ 20.9 B	USA
PerkinElmer PKI	92.2	-	-0.91 %	$ 14.7 B	USA
Pacific Biosciences of California PACB	185	$ 1.5	3.82 %	$ 450 M	USA
Quotient Limited QTNT	345	-	-11.32 %	$ 1.1 M	Schweiz
Precipio PRPO	19.9	$ 28.4	-0.37 %	$ 45.6 M	USA
Personalis PSNL	-11.5	$ 6.5	5.35 %	$ 385 M	USA
QIAGEN N.V. QGEN	122	-	-	$ 10.6 B	Niderland
Anixa Biosciences ANIX	275	$ 2.68	-0.56 %	$ 87 K	USA
Biomerica BMRA	172	$ 2.14	-0.93 %	$ 4.92 M	USA
BioNano Genomics BNGO	166	$ 1.17	0.17 %	$ 6.37 M	USA
Interpace Biosciences IDXG	62.9	$ 2.0	0.25 %	$ 8.85 M	USA